An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
about
Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancerFrontiers in cancer nanomedicine: directing mass transport through biological barriersSilica nanoparticles as a delivery system for nucleic acid-based reagents.Nonporous Silica Nanoparticles for Nanomedicine Application.Nanotechnology for breast cancer therapy.Silica-based multimodal/multifunctional nanoparticles for bioimaging and biosensing applications.A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin.Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy.Nanotechnology based platforms for survivin targeted drug discovery.Silica-based nanocomposites via reverse microemulsions: classifications, preparations, and applications.Inorganic nanovectors for nucleic acid delivery.Cationic niosomes an effective gene carrier composed of novel spermine-derivative cationic lipids: effect of central core structures.Efficacy of mesoporous silica nanoparticles in delivering BMP-2 plasmid DNA for in vitro osteogenic stimulation of mesenchymal stem cells.Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery.Preparation and in-vitro Evaluation of an Antisense-containing Cationic Liposome against Non-small Cell Lung Cancer: a Comparative Preparation Study.Chitosan-coated liposomes for intracellular oligonucleotides delivery: characteristics and cell uptake behavior.Mast cell accumulation precedes tissue fibrosis induced by intravenously administered amorphous silica nanoparticles.
P2860
Q24657308-74BDC2FD-7121-499C-813F-C197D65162FEQ33746335-F0BD2F23-BDF5-4A25-B184-677643EAE063Q34080775-A6298F3D-7A15-4B19-B6BD-B10D9AE5DAC9Q37131939-E1F0FB86-6682-48C2-A630-37BEDEB95638Q37229262-010AC160-D4DA-4571-AA63-191150132D99Q37241003-554DA20E-C0EF-4842-954E-22F29B1E9694Q37623985-262D2BC9-17C7-4B06-A79A-8D10E280ED06Q37624164-7F65489B-522D-467B-AE95-0316A61A2B40Q38040859-BD8A16F2-3489-434D-8F91-A1C6AA546222Q38190409-B0405522-D65E-4BA4-93FF-1827A6D034D0Q38383483-3CB0BA7A-A3D4-415A-A7B4-8C604F7E4AD1Q38808635-8EB05111-6321-48C0-BA91-C93F63B14CF2Q39237891-8D5275E4-0B10-47BD-A31B-1C6DD40224E9Q42431249-D0B44042-8E6C-44C2-8B76-72CCC2E002D7Q42927324-0C669970-EE4A-498C-9127-1705279C1A88Q44867756-226F2C5F-B396-4EE8-BB1F-548B70AA49A5Q50316763-32EF7A38-12F1-4B51-AC18-C1AD18817306
P2860
An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
An antisense oligonucleotide c ...... se inhibition of cancer cells.
@en
type
label
An antisense oligonucleotide c ...... se inhibition of cancer cells.
@en
prefLabel
An antisense oligonucleotide c ...... se inhibition of cancer cells.
@en
P2093
P1476
An antisense oligonucleotide c ...... se inhibition of cancer cells.
@en
P2093
Jiaofeng Peng
Kemin Wang
Weihong Tan
Xiaoxiao He
Xinli Xing
P304
P356
10.1016/J.NANO.2006.04.003
P577
2006-06-01T00:00:00Z